MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Familial Creutzfeldt-Jakob Disease with an E200K Mutation in Peru: A Case Report

    H. Sarapura-Castro, C. Cosentino, L. Torres-Ramirez, P. Parchi, A. Vishnevetsky, M. Inca-Martinez, E. Figueroa-Ildefonso, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

    Objective: To describe the clinical and molecular features of a familial Creutzfeldt-Jakob Disease (fCJD) case in Peru.  Background: Creutzfeldt - Jakob disease (CJD) is characterized…
  • 2017 International Congress

    Reliability of Continuous Parkinson’s Assessment Using Wearables

    D. Heldman, E. Urrea Mendoza, N. Mennucci, C. Zimmerman, J. Giuffrida, A. Hadley, Z. Mari, M. Burack, I. Itin, F. Revilla (Cleveland, OH, USA)

    Objective: To evaluate test-retest reliability and determine the optimal number of days of use for wearable sensors and a mobile software app to continuously and…
  • 2017 International Congress

    Instrumental Measurement of Stepping in Place – Detection of Asymmetry and Freezing of Gait

    K. Otte, T. Vater, T. Ellermeyer, L. Rasche, G. Wenzel, B. Kayser, S. Mansow-Model, A. Kühn, F. Paul, A. Brandt, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To detect freezing of gait (FoG) and quantify movement asymmetry from markerless full body motion capture with Microsoft Kinect™ during the execution of a…
  • 2017 International Congress

    The influence of neurorehabilitation on Parkinson medication

    V. Tomantschger, A. Tautscher-Basnett, M. Freimueller (Hermagor, Austria)

    Objective: To investigate the influence of neurorehabilitation on the dose changes of Parkinson medication over time.  Background: In progressive disorders such as Parkinson’s disease (PD),…
  • 2017 International Congress

    Determinant factors of treatment adherence in Parkinson’s disease

    I. Estrada-Bellmann, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías, P. Cortés-Estrada (Monterrey, Mexico)

    Objective: To determine factors predicting treatment adherence in patients with idiopathic Parkinson’s disease. Background: Parkinson’s disease is the second most common cause of neurodegenerative disease…
  • 2017 International Congress

    Interaction of dietary protein with levodopa in Parkinson disease.

    B. Sharma, A. Rassmann, T. Virmani (Little Rock, AR, USA)

    Objective: To study the effect of dietary protein on levodopa effectiveness in Parkinson disease (PD) patients.  Background: Levodopa transport across the blood brain barrier is…
  • 2017 International Congress

    How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?

    E. Okuyucu, M. Uzel, S. Colakoglu Yesıldag, M. Guntel (Hatay, Turkey)

    Objective: To clarify the possible associations of  levodopa / benserazidehydrochloride usage and  skin rashes. Background:   Levodopa/benserazide hydrochloride   is one of the best dopaminergic drug used…
  • 2017 International Congress

    Relation between REM-Sleep Behaviour Disorder and dysautonomic symptoms in Essential Tremor patients

    R. Barbosa, M. Mendonça, F. Ladeira, R. Miguel, P. Bugalho (Lisboa, Portugal)

    Objective: Assess the frequency of REM Sleep Behaviour Disorder (RBD) and dysautonomic symptoms in patients with Essential Tremor (ET), and evaluate the differences between ET-RBD…
  • 2017 International Congress

    Spectrum of non-motor symptoms in essential tremor in a Tunisian population

    M. Ben Djebara, I. Kacem, S. Mrabet, Y. Sidhom, B. Saguem, A. Nasri, A. Gargouri, R. Gouider (Manouba, Tunisia)

    Objective: Spectrum of non-motor symptoms in essential tremor in a Tunisian population Background: Several studies have recently lighted out the importance of NMS in ET.…
  • 2017 International Congress

    Video-oculography assessment in neurodegenerative ataxias and Neimann Pick Type C

    H. Hanagasi, Z. Karaarslan, B. Bilgiç, Z. Tüfekçioğlu, A. Demirtaş Tatlıdede, H. Gürvit, M. Emre (İstanbul, Turkey)

    Objective: To assess the role of video-oculography (VOG) in the differential diagnosis of neurodegenerative ataxias and NP-C by evaluating saccadic velocity and smooth pursuit gain…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley